[Use of recombinant activated factor vii in bronchoalveolar lavage in a case of pulmonary hemorrhage]

Med Intensiva. 2015 May;39(4):253-5. doi: 10.1016/j.medin.2014.06.010. Epub 2014 Sep 3.
[Article in Spanish]
No abstract available

Publication types

  • Letter

MeSH terms

  • Anticoagulants / adverse effects
  • Bronchoalveolar Lavage Fluid*
  • Bronchoscopy
  • Combined Modality Therapy
  • Comorbidity
  • Embolization, Therapeutic
  • Factor VIIa / administration & dosage
  • Factor VIIa / therapeutic use*
  • Female
  • Hemoptysis / diagnostic imaging
  • Hemoptysis / drug therapy*
  • Hemoptysis / etiology
  • Hemoptysis / therapy
  • Hemostatic Techniques
  • Humans
  • Middle Aged
  • Multiple Organ Failure / etiology
  • Pneumonia, Bacterial / complications
  • Postoperative Hemorrhage / diagnostic imaging
  • Postoperative Hemorrhage / drug therapy*
  • Postoperative Hemorrhage / etiology
  • Postoperative Hemorrhage / therapy
  • Pseudomonas Infections / complications
  • Recombinant Proteins / administration & dosage
  • Recombinant Proteins / therapeutic use
  • Shock, Septic / etiology
  • Tricuspid Valve Insufficiency / surgery

Substances

  • Anticoagulants
  • Recombinant Proteins
  • recombinant FVIIa
  • Factor VIIa